Hepatitis B Flare After Cessation of Nucleos(t)ide Analogue Therapy in HBeAg‐Negative Chronic Hepatitis B: To Retreat or Not to Retreat
Author:
- 18 August 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 73 (2) , 843-852
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With AdefovirGastroenterology, 2012
- A new role for an old marker, HBsAgJournal of Hepatology, 2010
- Control of cccDNA function in hepatitis B virus infectionJournal of Hepatology, 2009
- Hepatitis B virus infectionThe Lancet, 2009
- HBcAg-specific CD4+CD25+regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infectionJournal of Biomedical Science, 2006
- Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)‐positive patients with genotypes B and C: implication for early HBeAg seroconversionJournal of Viral Hepatitis, 2006
- Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon α-2b therapyGut, 2005
- Prednisolone Priming Enhances Th1 Response and Efficacy of Subsequent Lamivudine Therapy in Patients With Chronic Hepatitis BHepatology, 2000
- Acute exacerbation in chronic type B hepatitis: Comparison between HBeAg and antibody-positive patientsHepatology, 1987
- Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitisJournal of Hepatology, 1985